Acceptability of HPV Vaccine for Males and Preferences for Future Education Programs Among Appalachian Residents

American Journal of Men's Health

Volumn 8, Issue 2, 2014, Pages 167-174

  Reiter, Paul L ^a   Oldach, Benjamin R ^a   Randle, Katherine E ^a   Katz, Mira L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Appalachia; HPV; HPV vaccine; males

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGED; APPALACHIA; ARTICLE; FEMALE; HEALTH EDUCATION; HPV VACCINE; HUMAN; INFORMATION PROCESSING; MALE; MEN'S HEALTH; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; QUALITATIVE RESEARCH; UNITED STATES; WART VIRUS; YOUNG ADULT;

APPALACHIA; HPV; HPV VACCINE; MALES;

ADOLESCENT; ADULT; AGED; APPALACHIAN REGION; FEMALE; FOCUS GROUPS; HEALTH EDUCATION; HUMANS; MALE; MEN'S HEALTH; MIDDLE AGED; OHIO; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITATIVE RESEARCH; YOUNG ADULT;

EID: 84893342493     PISSN: 15579883     EISSN: 15579891     Source Type: Journal    
DOI: 10.1177/1557988313505319     Document Type: Article

References (39)

1. Cancer facts & figures 2013. Atlanta, GA: Author; 2013:.
2. Bednarczyk R. A.,Davis R.,Ault K.,Orenstein W.,Omer S. B.Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds.Pediatrics. 2012;130:798-805.
3. Brewer N. T.,Fazekas K. I.Predictors of HPV vaccine acceptability: A theory-informed, systematic review.Preventive Medicine. 2007;45:107-114.
4. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).Morbidity and Mortality Weekly Report. 2010;59 (20): 630-632.
5. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP).Morbidity and Mortality Weekly Report. 2011;60 (50): 1705-1708.
6. Centers for Disease Control and Prevention. (2012a). CDC vaccine price list. Retrieved from http://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html.
7. National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011.Morbidity and Mortality Weekly Report. 2012b;61:671-677.
8. Centers for Disease Control and Prevention. (2013). Vaccines for Children program (VFC). Retrieved from http://www.cdc.gov/vaccines/programs/vfc/index.html.
9. Christian W. J.,Christian A.,Hopenhayn C.Acceptance of the HPV vaccine for adolescent girls: Analysis of state-added questions from the BRFSS.Journal of Adolescent Health. 2009;44:437-445.
10. Dinh T. H.,Sternberg M.,Dunne E. F.,Markowitz L. E.Genital warts among 18- to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999-2004.Sexually Transmitted Diseases. 2008;35:357-360.
11. Dorell C. G.,Yankey D.,Santibanez T. A.,Markowitz L. E.Human papillomavirus vaccination series initiation and completion, 2008-2009.Pediatrics. 2011;128:830-839.
12. Elo S.,Kyngas H.The qualitative content analysis process.Journal of Advanced Nursing. 2008;62:107-115.
13. Ferris D. G.,Cromwell L.,Waller J. L.,Horn L.Most parents do not think receiving human papillomavirus vaccine would encourage sexual activity in their children.Journal of Lower Genital Tract Disease. 2010;14:179-184.
14. Gee J.,Naleway A.,Shui I.,Baggs J.,Yin R.,Li R., Weintraub E. S.Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink.Vaccine. 2011;29:8279-8284.
15. Gilbert P.,Brewer N. T.,Reiter P. L.,Ng T. W.,Smith J. S.HPV vaccine acceptability in heterosexual, gay, and bisexual men.American Journal of Men's Health. 2011;5:297-305.
16. Griebeler M.,Feferman H.,Gupta V.,Patel D.Parental beliefs and knowledge about male human papillomavirus vaccination in the U.S.: A survey of a pediatric clinic population.International Journal of Adolescent Medicine and Health. 2012;24:315-320.
17. HauptR. M.SylvesterG. C. (2010). HPV disease in males and vaccination: Implications and opportunities for pediatricians. Infectious Diseases in Children. Retrieved from http://www.pediatricsupersite.com/view.aspx?rid=66396.
18. Hopenhayn C.,Christian A.,Christian W. J.,Schoenberg N. E.Human papillomavirus vaccine: Knowledge and attitudes in two Appalachian Kentucky counties.Cancer Causes & Control. 2007;18:627-634.
19. Katz M. L.,Reiter P. L.,Heaner S.,Ruffin M. T.,Post D. M.,Paskett E. D.Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia.Vaccine. 2009;27:3945-3952.
20. Katz M. L.,Reiter P. L.,Kluhsman B. C.,Kennedy S.,Dwyer S.,Schoenberg N., Dignan M.Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states.Vaccine. 2009;27:3195-3200.
21. Laz T. H.,Rahman M.,Berenson A. B.Human papillomavirus vaccine uptake among 9-17 year old males in the United States: The National Health Interview Survey, 2010.Human Vaccines & Immunotherapeutics. 2013;9 (4):
22. Social determinants of health. Marmot M.Wilkinson R., ed. Oxford, England: Oxford University Press; 1999:.
23. McRee A. L.,Reiter P. L.,Brewer N. T.Vaccinating adolescent girls against human papillomavirus-Who decides?.Preventive Medicine. 2010;50:213-214.
24. McRee A. L.,Reiter P. L.,Chantala K.,Brewer N. T.Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?.Cancer Epidemiology, Biomarkers & Prevention. 2010;19:1937-1944.
25. Middleman A. B.,Tung J. S.At what sites are parents willing to have their 11 through 14-year-old adolescents immunized?.Vaccine. 2010;28:2674-2678.
26. National Institutes of Health. (2008). Centers for population health and health disparities. Retrieved from http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-09-001.html.
27. Oldach B. R.,Katz M. L.Ohio Appalachia public health department personnel: Human papillomavirus (HPV) vaccine availability, and acceptance and concerns among parents of male and female adolescents.Journal of Community Health. 2012;37:1157-1163.
28. PollardK.JacobsenL. A. (2012). The Appalachian region: A data overview from the 2006-2010 American Community Survey. Retrieved from http://www.arc.gov/assets/research_reports/PRB-DataOverview-2012.pdf.
29. Reiter P. L.,McRee A. L.,Pepper J. K.,Gilkey M. B.,Galbraith K. V.,Brewer N. T.Longitudinal predictors of HPV vaccination among a national sample of adolescent males.American Journal of Public Health. 2013;103:1419-1427.
30. Reiter P. L.,Brewer N. T.,Gottlieb S. L.,McRee A. L.,Smith J. S.How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen.Vaccine. 2009;27:6840-6844.
31. Reiter P. L.,Fisher J. L.,Hudson A. G.,Tucker T. C.,Plascak J. J.,Paskett E. D.Assessing the burden of HPV-related cancers in Appalachia.Human Vaccines & Immunotherapeutics. 2013;9 (1): 90-96.
32. Reiter P. L.,Gilkey M. B.,Brewer N. T.HPV vaccination among adolescent males: Results from the National Immunization Survey-Teen.Vaccine. 2013;31:2816-2821.
33. Reiter P. L.,Katz M. L.,Paskett E. D.HPV vaccination among adolescent females from Appalachia: Implications for cervical cancer disparities.Cancer Epidemiology, Biomarkers & Prevention. 2012;21:2220-2230.
34. Reiter P. L.,McRee A. L.,Gottlieb S. L.,Brewer N. T.HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure.Vaccine. 2010;28:6292-6297.
35. Reiter P. L.,McRee A. L.,Kadis J. A.,Brewer N. T.HPV vaccine and adolescent males.Vaccine. 2011;29:5595-5602.
36. Reiter P. L.,McRee A. L.,Pepper J. K.,Chantala K.,Brewer N. T.Improving human papillomavirus vaccine delivery: A national study of parents and their adolescent sons.Journal of Adolescent Health. 2012;51 (1): 32-37.
37. Reiter P. L.,Pendergraft W. F.,Brewer N. T.Meta-analysis of human papillomavirus infection concordance.Cancer Epidemiology, Biomarkers & Prevention. 2010;19:2916-2931.
38. Schuler C. L.,Reiter P. L.,Smith J. S.,Brewer N. T.Human papillomavirus vaccine and behavioural disinhibition.Sexually Transmitted Infections. 2011;87:349-353.
39. U.S. Food and Drug Administration. (2011). Gardasil. Retrieved from http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM094042.